VSee Health, Inc.

As of June 30, 2026, VSee Health, Inc. carries a market capitalization of 6.44M, placing it among publicly traded companies globally. Its enterprise value stands at 8.15M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

VSee Health, Inc.'s next confirmed earnings release is scheduled for September 28, 2026.

As of June 30, 2026, VSee Health, Inc. has 55.68M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.33, and the price-to-book ratio stands at 0.85.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.65 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.15M versus a market cap of 6.44M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, VSee Health, Inc. maintains a current ratio of 0.40, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 28.56, indicating elevated leverage, while an interest coverage ratio of -4.07 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 64,679.38 in revenue per employee across its workforce of 195.25, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, VSee Health, Inc. recorded 56,276.00 in income tax expense. The company reported a pretax loss of -13.76M and -9.89M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on August 5, 2026, VSee Health, Inc.'s stock has declined approximately 96.34% over the past 52 weeks. The 50-day moving average sits at 0.12, while the 200-day moving average is 0.35.

Over the twelve months ended June 30, 2026, VSee Health, Inc. generated 12.63M in revenue and converted that into -9.89M in net income, yielding earnings per share of -0.38. EBITDA reached -8.28M, while operating income came in at -11.17M.

As of June 30, 2026, VSee Health, Inc. holds 454,151.00 in cash and equivalents against 2.17M in total debt, resulting in a net debt position of 1.56M. Total book value stands at 7.59M, with working capital of -4.83M providing operational flexibility.

VSee Health, Inc. produced -6.31M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -41,214.00 in capital expenditures, free cash flow totaled -6.35M - equivalent to -0.18 per share.

Over the twelve months ended June 30, 2026, VSee Health, Inc. posted a gross margin of 42.06, reflecting its pricing power and cost economics. The operating margin of -88.44 and net profit margin of -78.34 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -151.13: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -106.07, meaning VSee Health, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, VSee Health, Inc. has an Altman Z-Score of -35.31, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.